MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6
Author:
Publisher
Elsevier BV
Subject
Transplantation,Immunology,Immunology and Allergy
Reference33 articles.
1. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer;Chen;PLoS One,2017
2. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat. Rev. Cancer,2014
3. First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?;Einhorn;J. Clin. Oncol.,2008
4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
5. Molecular mechanisms of cisplatin resistance;Galluzzi;Oncogene,2012
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review;Cancer Cell International;2023-11-20
2. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response;Pathology - Research and Practice;2023-11
3. MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review;Medical Oncology;2023-09-15
4. Long Noncoding RNA FENDRR Facilitates Progressions of Hemangioma Endothelial Cells via Sponging MicroRNA-424;INTERNATIONAL JOURNAL OF HUMAN GENETICS;2022-04-15
5. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response;Frontiers in Immunology;2022-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3